|
Re: Shenzhen Hepalink-Warrants Expiration
|
5
|
Resverlogix Corp.
|
Feb 05, 2022 01:49PM
|
|
Re: Shenzhen Hepalink-Warrants Expiration
|
3
|
Resverlogix Corp.
|
Feb 05, 2022 03:40PM
|
|
Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
4
|
Resverlogix Corp.
|
Feb 20, 2022 05:51PM
|
|
Re: https://themarkether...
|
1
|
Resverlogix Corp.
|
Feb 22, 2022 04:20PM
|
|
Re: New RVX Video - from Fontier Merchant Capital Group
|
7
|
Resverlogix Corp.
|
Feb 26, 2022 04:13PM
|
|
Re: Deja Vu All Over Again
|
10
|
Resverlogix Corp.
|
Mar 11, 2022 03:19PM
|
|
Re: Deja Vu All Over Again
|
7
|
Resverlogix Corp.
|
Mar 11, 2022 05:35PM
|
|
Re: Deja Vu All Over Again
|
9
|
Resverlogix Corp.
|
Mar 11, 2022 08:47PM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
6
|
Resverlogix Corp.
|
Mar 15, 2022 04:03PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
13
|
Resverlogix Corp.
|
Mar 17, 2022 11:43PM
|
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
10
|
Resverlogix Corp.
|
Mar 18, 2022 09:50PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
11
|
Resverlogix Corp.
|
Mar 25, 2022 04:14PM
|
|
Re: Was checking out SEDAR...
|
5
|
Zenith Epigenetics
|
Mar 28, 2022 06:00PM
|
|
Re: Covid China
|
5
|
Resverlogix Corp.
|
Mar 30, 2022 12:57AM
|
|
CEO Pay
|
14
|
Resverlogix Corp.
|
Mar 31, 2022 02:33PM
|
|
Re: RVX- Exempt Distribution
|
5
|
Resverlogix Corp.
|
Apr 01, 2022 11:42PM
|
|
Debt
|
7
|
Zenith Epigenetics
|
Apr 02, 2022 01:01PM
|
|
Re: Debt
|
4
|
Zenith Epigenetics
|
Apr 03, 2022 12:26PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
5
|
Zenith Epigenetics
|
Apr 21, 2022 11:57AM
|
|
BTD
|
11
|
Resverlogix Corp.
|
Apr 23, 2022 01:47PM
|
